← back to search

Andreas Neisius

L-3 Communications (United States) · DE
Area of research
Pulmonary and Respiratory Medicine · Pediatrics, Perinatology and Child Health
Research interest
Research interests include Kidney Stones and Urolithiasis Treatments, Pediatric Urology and Nephrology Studies, Ureteral procedures and complications, and Urinary Bladder and Prostate Research.
h-index
32
citations
4,824
works
185
NIH funding
primary concept
Medicine
email

Recent publications

Retrospective, multicenter evaluation of outcome in percutaneous nephrolitholapaxy using different energy sources for lithotripsy
Research Square 2026cited by 0position: middledoi
Which Measure of Stone Burden is the Best Predictor of Interventional Outcomes in Urolithiasis: A Systematic Review and Meta-analysis by the YAU Urolithiasis Working Group and EAU Urolithiasis Guidelines Panel
European Urology Open Science 2024cited by 24position: middledoi
Nivolumab + Ipilimumab as Immunotherapeutic Boost in Metastatic Urothelial Carcinoma
JAMA Oncology 2024cited by 5position: middledoi
Outcomes of Flexible Ureteroscopy vs Extracorporeal Shock Wave Lithotripsy for Renal Stones in Pediatric Patients: A European Association of Urology Urolithiasis Guidelines Systematic Review and Meta-Analysis
The Journal of Urology 2023cited by 19position: middledoi
Prospective Analysis of Versatility and User Satisfaction with a Novel Single-Use Cystoscope with Working Channel
Urologia Internationalis 2023cited by 2position: middledoi
Best Practice in Interventional Management of Urolithiasis: An Update from the European Association of Urology Guidelines Panel for Urolithiasis 2022
European Urology Focus 2022cited by 248position: middledoi
Prospective multicentre randomized double-blind placebo-controlled parallel group study on the efficacy and tolerability of StroVac® in patients with recurrent symptomatic uncomplicated bacterial urinary tract infections
International Urology and Nephrology 2022cited by 16position: lastdoi
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
The Lancet Oncology 2021cited by 644position: middledoi
Assessment of PI3K/mTOR/AKT Pathway Elements to Serve as Biomarkers and Therapeutic Targets in Penile Cancer
Cancers 2021cited by 13position: middledoi
Ureteral Stones: Shockwave Lithotripsy or Ureteroscopy, Which is Best?
European Urology 2021cited by 3position: lastdoi
Imaging modalities and treatment of paediatric upper tract urolithiasis: A systematic review and update on behalf of the EAU urolithiasis guidelines panel
Journal of Pediatric Urology 2020cited by 60position: middledoi
Radiation exposure during retrograde intrarenal surgery (RIRS): a prospective multicenter evaluation
World Journal of Urology 2020cited by 20position: middledoi
AR-V7 Protein Expression in Circulating Tumour Cells Is Not Predictive of Treatment Response in mCRPC
Urologia Internationalis 2020cited by 12position: middledoi
Evaluation of stone free rates in early versus delayed primary ureteroscopy: time does matter
World Journal of Urology 2020cited by 5position: middledoi
Treatment of Bladder Stones in Adults and Children: A Systematic Review and Meta-analysis on Behalf of the European Association of Urology Urolithiasis Guideline Panel
European Urology 2019cited by 89position: lastdoi
Stone-Free Rate after Treating Kidney Stones Exceeding 10 mm via Flexible Ureteroscopy: Can Endoscopic Assessment Replace Low-Dose Computed Tomography Control?
Urologia Internationalis 2019cited by 14position: lastdoi
Clinical outcomes and costs of reusable and single-use flexible ureterorenoscopes: a prospective cohort study
Urolithiasis 2018cited by 71position: lastdoi
Survival outcomes in patients with large (≥7cm) clear cell renal cell carcinomas treated with nephron-sparing surgery versus radical nephrectomy: Results of a multicenter cohort with long-term follow-up
PLoS ONE 2018cited by 54position: middledoi
Surgical treatment of large volume prostates: a matched pair analysis comparing the open, endoscopic (ThuVEP) and robotic approach
World Journal of Urology 2018cited by 39position: lastdoi
Future perspectives of flexible ureteroscopy
Current Opinion in Urology 2018cited by 30position: lastdoi
Docetaxel-rechallenge in castration-resistant prostate cancer: defining clinical factors for successful treatment response and improvement in overall survival
International Urology and Nephrology 2018cited by 28position: middledoi
Long-term results of ProACT primary and repeat implantation for treatment of stress urinary incontinence in men
World Journal of Urology 2018cited by 20position: middledoi
Urolithiasis: evaluation, dietary factors, and medical management: an update of the 2014 SIU-ICUD international consultation on stone disease
World Journal of Urology 2017cited by 43position: middledoi
Hat die extrakorporale Stoßwellenlithotripsie noch einen Stellenwert?
Der Urologe 2017cited by 6position: firstdoi
S2k-Leitlinie zur Diagnostik, Therapie und Metaphylaxe der Urolithiasis (AWMF 043/025)
Der Urologe 2016cited by 40position: middledoi
Differences in Overall and Cancer-specific Survival of Patients Presenting With Chromophobe Versus Clear Cell Renal Cell Carcinoma: A Propensity Score Matched Analysis
Urology 2016cited by 22position: middledoi
Balloon Dilation of the Ureter: A Contemporary Review of Outcomes and Complications
The Journal of Urology 2015cited by 64position: middledoi
Treatment Response in Patients with Stones, and Low Urinary pH and Hypocitraturia Stratified by Body Mass Index
The Journal of Urology 2015cited by 30position: middledoi
Evaluation of Novel Ball-Tip Holmium Laser Fiber: Impact on Ureteroscope Performance and Fragmentation Efficiency
Journal of Endourology 2015cited by 29position: middledoi
Bone scintigraphy predicts bisphosphonate-induced osteonecrosis of the jaw (BRONJ) in patients with metastatic castration-resistant prostate cancer (mCRPC)
Clinical Oral Investigations 2015cited by 28position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Glenn M. Preminger · General Marble (Greece)15 papers (2012–2015)Michael E. Lipkin · Duke University13 papers (2012–2015) · 8 papers (2012–2015)William H. Turner · Cambridge University Hospitals NHS Foundation Trust7 papers (2012–2013)T.B. Madden · University of Liverpool7 papers (2012–2013) · 7 papers (2012–2013)Michael N. Ferrandino · Weed Science Society of America7 papers (2012–2015)Dirk De Ridder · KU Leuven7 papers (2012–2013)Frederik C. Roos · Johannes Gutenberg University Mainz7 papers (2013–2018)Arjun Nambiar · Swansea University7 papers (2012–2013) · 7 papers (2012–2013)Francisco Cruz · Universidade Federal do Rio de Janeiro7 papers (2012–2013)Nicholas Kuntz · Lurie Children's Hospital7 papers (2013–2015)Christian Thomas · German Cancer Research Center7 papers (2013–2020)Ruud Bosch · Utrecht University7 papers (2012–2013)R.S. Pickard · Newcastle University7 papers (2012–2013) · 6 papers (2019–2024)Christian Hampel · Johannes Gutenberg University Mainz5 papers (2013–2018)Andreas Skolarikos · National and Kapodistrian University of Athens5 papers (2019–2024)Matvey Tsivian · Medical University of South Carolina5 papers (2013–2015)